Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesPreferred Shares RepurchasedSales of Property, Plant and EquipmentShares Issued
Growth Metrics
Income Statement
Others
Ratios

Gladstone Land (LANDM) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Gladstone Land (LANDM) over the last 11 years, with Q3 2025 value amounting to $316000.0.

  • Gladstone Land's Asset Writedowns and Impairment fell 8499.53% to $316000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $422000.0, marking a year-over-year decrease of 8245.32%. This contributed to the annual value of $2.1 million for FY2024, which is 131342.28% up from last year.
  • According to the latest figures from Q3 2025, Gladstone Land's Asset Writedowns and Impairment is $316000.0, which was down 8499.53% from $68000.0 recorded in Q2 2025.
  • Gladstone Land's 5-year Asset Writedowns and Impairment high stood at $2.1 million for Q3 2024, and its period low was $2000.0 during Q4 2021.
  • Over the past 5 years, Gladstone Land's median Asset Writedowns and Impairment value was $52500.0 (recorded in 2022), while the average stood at $264357.1.
  • In the last 5 years, Gladstone Land's Asset Writedowns and Impairment soared by 1452000.0% in 2022 and then plummeted by 8499.53% in 2025.
  • Over the past 5 years, Gladstone Land's Asset Writedowns and Impairment (Quarter) stood at $2000.0 in 2021, then skyrocketed by 36450.0% to $731000.0 in 2022, then plummeted by 89.19% to $79000.0 in 2023, then soared by 2565.82% to $2.1 million in 2024, then plummeted by 85.0% to $316000.0 in 2025.
  • Its Asset Writedowns and Impairment stands at $316000.0 for Q3 2025, versus $68000.0 for Q2 2025 and $38000.0 for Q1 2025.